Understanding the role patient subtype plays in PsA treatment selection

Challenge

Understanding the drivers of treatment choice in the real world to see if certain patient subtypes see greater use of specific, competitive treatments and which are favored for lines of therapy. 

Solution

Leverage OM1 linked clinical EMR and claims data along with PROs and ClinROs; Create patient severity subtypes using CDAI and RAPID 3 scores

PsA patients followed longitudinally with deep clinical data

29%

of patients w/ at least 1 CDAI score

40%

of patients w/ at least 1 RAPID 3 score